-
Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer
Source: Buzz FX / 13 Jan 2025 10:46:16 America/Chicago
Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective decreas
Read more...